Showing results (111-120 of 148) with videos related to
Sort By:
Pageof 15
Dementia (Basel, Switzerland)|July 1, 1995
Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer diseaseM Bobinski, J Wegiel, H M Wisniewski, et al.Neurobiology of Aging|November 1, 1996
Neurofibrillary pathology--correlation with hippocampal formation atrophy in Alzheimer diseaseM Bobinski, J Wegiel, H M Wisniewski, et al.Neurology|September 1, 1996
Hippocampal formation size predicts declining memory performance in normal agingJ Golomb, A Kluger, M J de Leon, et al.Journal of the American Geriatrics Society|May 1, 1992
Milacemide: a placebo-controlled study in senile dementia of the Alzheimer typeM W Dysken, J Mendels, P LeWitt, et al.Radiology|November 1, 1983
Ventricular volume and cognitive deficit: a computed tomographic studyA E George, M J de Leon, S Rosenbloom, et al.Brain Research|January 23, 1999
Cerebellar atrophy in Alzheimer's disease-clinicopathological correlationsJ Wegiel, H M Wisniewski, J Dziewiatkowski, et al.Alzheimer Disease and Associated Disorders|January 1, 1997
Informant-rated activities-of-daily-living (ADL) assessments: results of a study of 141 items in the U.S.A., Germany, Russia, and Greece from the International ADL Scale Development ProjectH Lehfeld, B Reisberg, S Finkel, et al.Neurology|January 30, 2009
Donepezil treatment of patients with MCI: a 48-week randomized, placebo-controlled trialR S Doody, S H Ferris, S Salloway, et al.The American Journal of Psychiatry|April 1, 1986
Dexamethasone suppression in dementia, depression, and normal agingA Georgotas, R E McCue, O M Kim, et al.International Psychogeriatrics|December 2, 2008
The wills of older people: risk factors for undue influenceC Peisah, S Finkel, K Shulman, et al.Pageof 15